Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration

Por Fan, F, Samuel, S, Gaur, P, Lu, J, Dallas, N A, Xia, L, Bose, D, Ramachandran, V, Ellis, L M
Publicado em 2011